Article
HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients.
Frontiers in immunology - 1 Jan 2021
Satapornpong Patompong, Pratoomwun Jirawat, Rerknimitr Pawinee, Klaewsongkram Jettanong, Nakkam Nontaya, Rungrotmongkol Thanyada, Konyoung Parinya, Saksit Niwat, Mahakkanukrauh Ajanee, Amornpinyo Warayuwadee, Khunarkornsiri Usanee, Tempark Therdpong, Wantavornprasert Kittipong, Jinda Pimonpan, Koomdee Napatrupron, Jantararoungtong Thawinee, Rerkpattanapipat Ticha, Wang Chuang-Wei, Naisbitt Dean, Tassaneeyakul Wichittra, Ariyachaipanich Manasalak, Roonghiranwat Thapana, Pirmohamed Munir, Chung Wen-Hung, Sukasem Chonlaphat
Abstract excerpt
HLA-B*13:01 allele has been identified as the genetic determinant of dapsone hypersensitivity syndrome (DHS) among leprosy and non-leprosy patients in several studies. Dapsone hydroxylamine (DDS-NHOH), an active metabolite of dapsone, has been believed to be responsible for DHS. However, studies have not highlighted the importance of other genetic polymorphisms in dapsone-induced severe cutaneous adverse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
